Solar Foods to list on Nasdaq First North Finland
29 August 2024
Agronomics Ltd
("Agronomics" or the "Company")
Solar Foods to list on Nasdaq First North Growth Market Finland
Agronomics (LON: ANIC), a leading listed company in the field of cellular agriculture, is pleased to report that portfolio company Solar Foods Oyj ("Solar Foods") has announced that it is planning a listing and application for admission of its shares to trading on the Nasdaq First North Growth Market Finland. The planned listing will be carried out in September 2024. No share issue or sale will be arranged in connection with the listing. Solar Foods represents 6.7% of Agronomic's last stated Net Asset Value (30/06/2024).
Solar Foods explains that the main purpose of the listing is to enable them to enact their global growth strategy, which involves the commissioning of Factory 02, a commercial-scale production facility. Solar Foods is already a notably advanced company in the field, given its wholly owned and fully operational facility (Factory 01), which launched in April this year. This facility can produce 160 tonnes of Solein® per year, which can be used as a food raw material with high protein content and which will be sold to customers for testing, marketing and piloting new products. Factory 02 is critical to Solar Foods' growth strategy, given it is estimated to be 50-100 times larger than Factory 01, allowing for the production of Solein® at a favourable cost of EUR 4.3-5.2/kg, which is expected to decrease further with future technical developments.
Along with financing the construction of Factory 02 to scale production, achieving regulatory approval in other jurisdictions is key to Solar Foods' growth strategy. Solar Foods' management expects to achieve self-affirmed Generally Recognised as Safe status in the US by the end of 2024, allowing sales to begin and making the US the second jurisdiction to approve Solein® alongside Singapore. Solar Foods also has applications pending approval in the UK and in the EU.
The direct listing on the Nasdaq First North Growth Market Finland will allow the company to access new and larger pools of capital, facilitating the implementation of its growth strategy. Following the close of its oversubscribed EUR 16 million Series B round on the Finnish fundraising platform Springvest Oyj, Solar Foods meets the requirements for the listing and is well positioned, given the demand for its shares has been tested.
Jim Mellon, Co-Founder and Executive Chair of Agronomics commented:
"Solar Foods has shown an impressive ability to execute particularly regarding securing the financing for and the construction of Factory 01, which makes the company one of few in the field with a wholly owned and fully operational facility. We are confident in the ability of Solar Foods' management team to deliver on the next stage of its growth strategy, investing in developing and expanding its production capability and the commercialisation of products in key markets where regulatory approval is imminent."
For the Solar Foods' full announcement please see the following link:
https://investors.solarfoods.com/release/0fefa5b3-76a7-4c99-9dc8-e9943a466aff
Solar Foods produces protein using carbon dioxide and electricity. Solein® production, irrespective of weather and climate conditions, liberates global protein production from the constraints of traditional agriculture. Solar Foods, founded in 2017 in Espoo, Finland by Dr Pasi Vainikka, Dr Juha-Pekka Pitkänen, Sami Holmström, Jari Tuovinen, Professor Jero Ahola, and Janne Mäkelä as a spinoff from VTT Technical Research Centre of Finland and LUT University. www.solarfoods.com.
About Agronomics
Agronomics is a leading London-listed company focussing on investment opportunities within the field of cellular agriculture. The Company has established a portfolio of over 20 companies in this rapidly advancing sector. It seeks to invest in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals and improve food security for the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/.
For further information please contact:
|
Agronomics Limited |
Beaumont Cornish Limited |
Canaccord Genuity Limited |
Cavendish Capital Markets Limited |
Peterhouse Capital Limited |
SEC Newgate |
|
The Company |
Nomad |
Joint Broker |
Joint Broker |
Joint Broker |
Public Relations |
|
Jim Mellon Denham Eke |
Roland Cornish James Biddle |
Andrew Potts Harry Pardoe Alex Aylen (Head of Equities) |
Charlie Combe Michael Johnson |
Lucy Williams Charles Goodfellow |
Bob Huxford Anthony Hughes |
|
+44 (0) 1624 639396 info@agronomics.im |
+44 (0) 207 628 3396 |
+44 (0) 207 523 8000 |
+44 (0) 207 397 8900 |
+44 (0) 207 469 0936 |
agronomics@secnewgate.co.uk |
Nominated Adviser
Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated Adviser and is authorised and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 4 hours ago Johnson Matthey
- 5 hours ago Galliford Try
- 5 hours ago Galliford Try
- 5 hours ago Centrica
- 6 hours ago Smith & Nephew